Cellbri
2-6/F, Block 3A, Hengtaiyu Building, Guangming District, Shenzhen, Guangdong, China
Overview
赛桥生物 is a biotechnology service provider whose main businesses include biotechnology, medical technology, natural science research and experimental development, and medical-technology R&D. The company recently completed a B round financing of nearly ¥200 million RMB. The round was led by 本草资本, with 弘盛资本 participating as a follow-on investor. Existing shareholders 水木创投, 腾业创投, 昌发展 and 深圳天使母基金 also continued to increase their investments in this round. The company said the financing will be used to accelerate the commercialization of new-quality production equipment. The report was published by DoNews on 2024-06-14 (sourced from IT桔子).
- Total raised
- $28M
- Funding rounds
- 1
- Latest round
- Series B
- Latest activity
- Jun 2024
Industries
- Machinery Manufacturing
- Manufacturing
- Retail
Recent funding
Series B
Jun 2024
$28M
Team
No current team members are available.